UCB SA (UCBJY)
93.74
+2.57
(+2.82%)
USD |
OTCM |
Nov 22, 16:00
UCB Debt to Equity Ratio: 0.3178 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.3178 |
| December 31, 2023 | 0.3206 |
| June 30, 2023 | 0.3029 |
| December 31, 2022 | 0.3045 |
| June 30, 2022 | 0.3207 |
| December 31, 2021 | 0.2371 |
| June 30, 2021 | 0.2566 |
| December 31, 2020 | 0.3627 |
| June 30, 2020 | 0.3909 |
| December 31, 2019 | 0.1679 |
| June 30, 2019 | 0.1966 |
| December 31, 2018 | 0.2216 |
| June 30, 2018 | 0.2596 |
| December 31, 2017 | 0.2697 |
| June 30, 2017 | 0.2799 |
| Date | Value |
|---|---|
| December 31, 2016 | 0.2855 |
| June 30, 2016 | 0.416 |
| December 31, 2015 | 0.3877 |
| June 30, 2015 | 0.44 |
| December 31, 2014 | 0.4214 |
| June 30, 2014 | 0.4923 |
| December 31, 2013 | 0.6142 |
| June 30, 2013 | 0.5485 |
| December 31, 2012 | 0.4512 |
| June 30, 2012 | 0.4363 |
| December 31, 2011 | 0.3826 |
| June 30, 2011 | 0.371 |
| December 31, 2010 | 0.4501 |
| June 30, 2010 | 0.5887 |
| December 31, 2009 | 0.5375 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1679
Minimum
Dec 2019
0.3909
Maximum
Jun 2020
0.2982
Average
0.3112
Median
Debt to Equity Ratio Benchmarks
| Galapagos NV | 0.00 |
| Mithra Pharmaceuticals SA | -19.15 |
| Nyxoah SA | 0.1866 |
| Celyad Oncology SA | 0.00 |
| MDxHealth SA | 3.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 16.75B |
| Total Liabilities (Quarterly) | 7.156B |
| Shareholders Equity (Quarterly) | 9.597B |
| Current Ratio | 1.187 |
| Net Debt Paydown Yield | -0.11% |